Furthermore, high levels of IL-8 and VEGF are related to reduced survival of NSCLC patients [56, 61], and basal levels of VEGF and IL-22 in SCLC patients are associated with a poor prognosis [27, 64, 65, 68–70]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.